SCHEMBL30950282

SCHEMBL30950282

COc1ccc(Cc2cnc(SC)nc2SC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.44
HTT P42858 1/20 0.43
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP11B1 P15538 4/20 0.40
CYP11B2 P19099 4/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP2D6 P10635 1/20 0.40
ATM Q13315 1/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.40
CSF1R P07333 2/20 0.39
NTRK2 Q16620 2/20 0.39
NTRK1 P04629 1/20 0.39
NTRK3 Q16288 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15634008 0.73 HTT (0.50) HTTALDH1A1L3MBTL1MEN1MAPT
SCHEMBL4712339 0.71 HTT (0.76) HTTMAPTPOLBSMN1; SMN2LMNA
SCHEMBL14874665 0.70 HTT (0.50) HTTALDH1A1MEN1KMT2ACYP11B1
SCHEMBL27585502 0.70 NPSR1 (0.44) LTA4HALDH1A1CYP11B1CYP11B2POLB
SCHEMBL1425001 0.70 LTA4H (0.81) LTA4HALDH1A1SMN1; SMN2CYP2D6ATM
SCHEMBL25986524 0.70 LTA4H (0.81) LTA4HALDH1A1SMN1; SMN2CYP2D6ATM
SCHEMBL27884 0.70 LTA4H (0.81) LTA4HALDH1A1SMN1; SMN2CYP2D6ATM
SCHEMBL23094537 0.70 HTT (0.42) HTTALDH1A1MEN1MAPTKMT2A
SCHEMBL23094450 0.70 MEN1 (0.39) HTTALDH1A1MEN1MAPTKMT2A
SCHEMBL6620402 0.69 NPC1 (0.43) HTTALDH1A1L3MBTL1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 CN disclosed